Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1552-2026

Beckman Coulter Mishima K.K. recalls DxC 700 AU

Beckman Coulter Mishima K.K.Sunto-Gun, JapanReported Mar 18, 2026 · 4 months ago
Legal News Analyst ·

Reason for recall

A delay in results may occur. When clinical chemistry analyzer calibration monitor with PC installed with Microsoft SQL Server 2022 Express is open beyond15 minutes may lead to: Reagent Blank and calibration databases not opening errors: CAL History DB Open Error.., RB History DB Open Error..; system will stop analyzing, firm service must visit to apply software solution; may lead to delay in diagnosis and/or patient treatment.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • DxC 700 AU, REF: B86444B86446
    144 affected lots
    2022B86444/14987666542545/2025060063202506007320250600742025060075202506007920250600852025060086
    +136 more202506008720250600912025060098202506009920250601242025060125202506012620250601272025060128202506012920250701392025070156202507015920250701602025070161202507016420250701672025070168202507016920250701782025070180202507018120250701822025070184202507018620250701912025070192202507019320250701942025070204202508020820250802172025080219202508023620250802372025080238202508024120250802422025080246202508024720250802502025090266202509026720250902702025090271202509027320250902742025090275202509028120250902832025090285202509028620250902872025090289202509029020250902912025090292202509029320250902942025090295202509029620250902972025090298202509029920250903012025090302202509030320250903042025090306202510037020251003712025100372202510037320251004212025100422202510042320251004242025100425202510042620251004272025110428202511042920251104372025110442202511044520251104522025110454202511045620251104572025110458202511046220251204642025120468202512046920251204712025120475202512047720251204782025120479202512048020251204822025120483202512048420251204852025120486202512048720251204882025120489202512049020251204922025120493202512049420251204952025120496B86446/14987666542514/202509027720250902842022B86444/14987666542545/2017050064201710017420180303122018040352201810056120181105992019010712201901071320191111702021021852202110231820211224582022042631202205270520220627752023063701202406440820240644192024064440
DistributionShow details

US Nationwide distribution including in the states of NE, WA, PA, CA, AZ, NC, TX, NV, CT, AL, NJ, TN, MT, ID, GA, SC, OH, KS, WI, HI, FL, VA, MI, NH, ME, NY, OR, LA, PR, MN, IL, MD, MO, MS, OK, AR.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Source: U.S. FDA openFDA device enforcement reports. This summary is informational and may lag or differ from the official record. Always verify against the FDA before acting.

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls